Graduate Research Papers

Availability

Open Access Graduate Research Paper

Abstract

The critical understanding, on which all else hinges in the biopharmaceutical industry, is that value is only added when a drug or a biologic is produced as a safe, efficacious first-pass product, in an efficient and effective manner. Every other activity is an expense and a cost to the company. In a tightly regulated industry that is facing turbulent times, the need to reconcile rising costs while still maintaining quality within the processes and products is imperative within the biopharma manufacturing sector. Current literature suggests that data science will have major implications in the future of biopharmaceutical manufacturing, however this emerging field still faces a long road for development and refinement for systematic use within manufacturing. Nonetheless, the strategies behind lean and data science essentially embody the same purpose: reduce waste and inefficiencies within the production flow and processes. The purpose of this paper is to demonstrate the feasibility of using big data analytics as an advanced lean manufacturing tool, as well as propose a possible model for integration with respect to constraints and challenges faced with utilizing big data analytics within the biopharma manufacturing sector.

Year of Submission

2019

Degree Name

Master of Science

Department

Department of Technology

First Advisor

Julie Zhang

Comments

If you are the rightful copyright holder of this graduate research paper and wish to have it removed from the Open Access Collection, please submit an email request to scholarworks@uni.edu. Include your name and clearly identify the thesis by full title and author as shown on the work.

Date Original

5-1-2019

Object Description

1 PDF file (31 pages)

Download

Comments?

Share

COinS